LCK JNK 1 LLC - 09 Feb 2025 SCHEDULE 13G Report for Scinai Immunotherapeutics Ltd. American Depositary Shares, each representing 4,000 Ordinary Shares, no par value

Filing Manager: LCK JNK 1 LLC
Reporting Manager: LCK JNK 1 LLC
Security: Scinai Immunotherapeutics Ltd. American Depositary Shares, each representing 4,000 Ordinary Shares, no par value
Shares outstanding: 850,074 shares
Disclosed Ownership: 80,757 shares
Ownership: 9.5%
Form type: SCHEDULE 13G
Filing time: 24 Feb 2025, 06:04:51 UTC
Date of event: 09 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
LCK JNK 1 LLC	9.5%	80,757	80,757	0	/s/ Richard J. Kertzman	Richard J. Kertzman / Sole Member